Holen Sie sich die Stockscreener-App
4.85
10.48%
0.46
Schlusskurs vom Vortag:
$4.39
Offen:
$4.42
24-Stunden-Volumen:
9.60M
Relative Volume:
1.51
Marktkapitalisierung:
$1.66B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-75.80M
KGV:
-13.86
EPS:
-0.35
Netto-Cashflow:
$-68.07M
1W Leistung:
+42.23%
1M Leistung:
+49.69%
6M Leistung:
+127.70%
1J Leistung:
+110.87%
1-Tages-Spanne:
$4.41
$4.87
1-Wochen-Bereich:
$3.45
$4.87
52-Wochen-Spanne:
$1.54
$4.87
Nuvation Bio Inc Stock (NUVB) Company Profile
Firmenname
Nuvation Bio Inc
Sektor
Branche
Telefon
(415) 754-3517
Adresse
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Vergleichen Sie NUVB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
4.85 | 1.50B | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Eingeleitet | Jefferies | Buy |
| 2025-04-23 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-03-27 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-01-06 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-02 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-04-06 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-03-08 | Eingeleitet | BTIG Research | Buy |
| 2021-03-08 | Eingeleitet | Cowen | Outperform |
| 2021-03-08 | Eingeleitet | Jefferies | Buy |
| 2021-03-08 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Nuvation Bio Inc Aktie (NUVB) Neueste Nachrichten
Chart based exit strategy for Nuvation Bio Inc.Market Performance Report & Free Fast Entry Momentum Trade Alerts - newser.com
Sector ETF performance correlation with Nuvation Bio Inc.Long Setup & Expert Approved Momentum Trade Ideas - newser.com
Key metrics from Nuvation Bio Inc.’s quarterly dataJuly 2025 Summary & Precise Trade Entry Recommendations - newser.com
Will Nuvation Bio Inc. Warrants stock announce a stock splitMarket Growth Report & Pattern Based Trade Signal System - newser.com
How big funds are accumulating Nuvation Bio Inc. Warrants stockWeekly Earnings Recap & Real-Time Stock Price Movement Reports - newser.com
Can Nuvation Bio Inc. stock deliver surprise earnings beatJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com
Has Nuvation Bio Inc. found a price floorJuly 2025 Catalysts & Consistent Income Trade Recommendations - newser.com
How Nuvation Bio Inc. Warrants stock compares with tech leadersPortfolio Gains Report & Technical Confirmation Trade Alerts - newser.com
How Nuvation Bio Inc. Warrants stock behaves in tightening cyclesMarket Trend Summary & AI Forecast Swing Trade Picks - newser.com
Is Nuvation Bio Inc. Warrants stock undervalued after correctionJuly 2025 Institutional & Technical Buy Zone Confirmation - newser.com
Will Nuvation Bio Inc. price bounce be sustainableMarket Movement Recap & Detailed Earnings Play Alerts - newser.com
Nuvation Bio Inc. Class A (NUVB) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Why Nuvation Bio Inc. stock is a must watch in 2025Market Trend Report & Fast Moving Stock Trade Plans - newser.com
Nuvation Bio enrolls first patient in phase 3 trial for glioma treatment - Investing.com Canada
Nuvation Bio enrolls first patient in phase 3 trial for glioma treatment By Investing.com - Investing.com South Africa
Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma - Investing News Network
Real time pattern detection on Nuvation Bio Inc. stockWeekly Profit Summary & Consistent Return Investment Signals - newser.com
Nuvation Bio stock hits 52-week high at 4.09 USD By Investing.com - Investing.com Nigeria
Can Nuvation Bio Inc. Class stock resist broad market declinesWeekly Risk Report & AI Powered Trade Plan Recommendations - newser.com
Is Nuvation Bio Inc. stock ready for a breakoutJuly 2025 Update & Trade Opportunity Analysis - newser.com
Has Nuvation Bio Inc. formed a bullish divergenceWeekly Market Report & Verified Stock Trade Ideas - newser.com
Finanzdaten der Nuvation Bio Inc-Aktie (NUVB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):